Back

PCSK9 inhibitors and incidence of arrhythmias in clinical practice: a phase IV multicentric study

16 April 2023 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: ePoster session 51 Arrhythmias EHRA Premium Access EHRA 2023

About the speaker

Photo
Doctor Giulia Stronati

Marche Polytechnic University of Ancona, Ancona (Italy)

9 More presentations in this session

Presentation thumbnail
Long-term outcome in patients with heart failure and diabetes mellitus treated with cardiac resynchronization therapy
Mrs E. Jedrzejczyk-Patej (Zabrze, PL)
Abstract Slides
Presentation thumbnail
Left ventricular global strain and duration of QRS complex as predictors of prognosis after cardiac resynchronization therapy
Doctor A. Mashal (Cairo, EG)
Abstract Slides
Presentation thumbnail
Both LBBP and LVSP significantly improve ventricular dyssynchrony and effectivity of LV performance compared to RV apical pacing in heart failure patients with LBBB and an indication to CRT
Doctor K. Curila (Prague, CZ)
Abstract Slides
Presentation thumbnail
Lowest peak central venous pressure correlates with highest invasive arterial blood pressure as a method for optimising AV delay in post-surgical temporary pacing
Doctor A. Tindale (London, GB)
Abstract Slides
Presentation thumbnail
Analysis of the effects of atrial pacing on the timing of left ventricular pressure rise in normal conduction and left bundle branch block
Mr M. Marciniak (PL)
Abstract Slides

Access the full session

Session thumbnail
ePoster session 51

The Event

Event poster

EHRA 2023

16 April - 18 April 2023
You may be interested in
thumbnail
Congress Session
How to prescribe exercise for people with valvular heart disease or hypertension
thumbnail
Congress Presentation
Exercise and cardiovascular risk: friend or foe? - discussion
thumbnail
Congress Presentation
Athletes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources